Darren Shafren

Founder at ImmVirX Pty Ltd.

Health Technology

Consumer Services

Commercial Services

Profile

Darren Shafren is the founder of ImmVirX Pty Ltd.
He is currently an Associate Professor at The University of Newcastle.
Previously, he served as the Chief Scientific Officer at Viralytics Pty Ltd.
from 2009 to 2019.

Darren Shafren active positions

Companies	Position	Start
The University of Newcastle	Corporate Officer/Principal	-
ImmVirX Pty Ltd. ImmVirX Pty Ltd. Miscellaneous Commercial ServicesCommercial Services ImmVirX Pty Ltd. develops oncotic viral immunotherapy. The Australian company was founded in 2019 by Malcolm L. McColl and Darren Shafren. Malcolm L. McColl has been the CEO since 2019.	Founder	-

All active positions of Darren Shafren

Former positions of Darren Shafren

Companies	Position	End
VIRALYTICS LTD.	Director of Research - Equity	25/10/2009

See the detail of Darren Shafren's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Darren Shafren's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Viralytics Pty Ltd. Viralytics Pty Ltd. BiotechnologyHealth Technology Viralytics Pty Ltd. engages in the development and commercialization of oncolytic immunotherapies that harness the power of certain viruses to infect and kill cancer cells. Its product, CAVATAK, is a genetically unmodified proprietary formulation of the common cold Coxsackievirus Type A21. The company was founded in 1984 and is headquartered in Sydney, Australia.	Health Technology
ImmVirX Pty Ltd. ImmVirX Pty Ltd. Miscellaneous Commercial ServicesCommercial Services ImmVirX Pty Ltd. develops oncotic viral immunotherapy. The Australian company was founded in 2019 by Malcolm L. McColl and Darren Shafren. Malcolm L. McColl has been the CEO since 2019.	Commercial Services